DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

SINDUSFARMA

2019 年 11 月 13 日 8:00 上午 - 2019 年 11 月 13 日 5:30 下午

Rua Alvorada, 1280 - Vila Olimpia, Sao Paulo - SP, 04550-044, Brazil

Latin America Pharmacovigilance and Risk Management Strategies Workshop

The premier meeting to discuss the current safety, pharmacovigilance, and risk management strategies landscape in LATAM.

Session 3: Risk Management

Session Chair(s)

Michele  Lawall Dornelas

Michele Lawall Dornelas

Pharmacovigilance Manager

AbbVie, Brazil

Bianca  Passos, MBA, RPH

Bianca Passos, MBA, RPH

Country Safety Head - Brazil

Sanofi, Brazil

Risk Management aims to ensure that the benefit-risk profile of a medicinal product is managed optimally during the product lifecycle, knowledge gaps at the time of authorization are elucidated, and risks are further quantified and characterized over time. Risk Management, including periodic signal detection and risk minimization, is receiving more and more attention from regulators and industry. This session will provide an overview on what is expected regarding this matter and best-practices performed by other players, such as Health Authorities.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Analyze the importance of planning pharmacovigilance activities and risk minimization measures
  • Develop and implement RMPs and RMM
  • Discuss how to perform signal detection and identify relevant risks that should be described for each drug
  • Assess the effectiveness of proposed measures

Speaker(s)

Pedro  Lima, DrMed, MSC

Industry Perspective on Signal Detection and Risk Management: From the Theory to Decision Making - Practical Examples from the Perspective of Local Surveillance

Pedro Lima, DrMed, MSC

Sanofi, Brazil

Regions Medical Safety Head

Maria   Lucia Buziqui Piruzeli, MD

Industry Perspective on Signal Detection and Risk Management: From the Theory to Decision Making - Practical Examples from the Perspective of Global Surveillance

Maria Lucia Buziqui Piruzeli, MD

Eli Lilly & Company, Brazil

Medical Advisor – Global Patient Safety

Luis Henrique  de Souza Teodoro, MSC

Industry Perspective on Signal Detection and Risk Management: From the Theory to Decision Making - Practical Examples from the Perspective of Global Surveillance

Luis Henrique de Souza Teodoro, MSC

Eli Lilly & Company, Brazil

Clinical Surveillance Scientist

Helaine  Capucho, DRSC

Health Literacy and Practical Implementation: How the Risk Management Plans Defined by the MAH and Industries are Translated into the HCP Routine

Helaine Capucho, DRSC

University of Brasilia , Brazil

Professor

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。